Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (GB:0QIU)
LSE:0QIU
0QIU Analyst Ratings
Moderate Buy
7 Buy
5 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0QIU Stock 12 Month Forecast
Average Price Target
kr743.58
▲(55.22% Upside)
| Highest Price Targetkr1,000.00 | Average Price Targetkr743.58 | Lowest Price Targetkr515.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
J.P. Morgan
Reiterated
03/28/25
Bank of America Securities
Reiterated
03/28/25
Morgan Stanley
Reiterated
03/27/25
Berenberg Bank
Reiterated
03/24/25
Deutsche Bank
Reiterated
03/24/25
Kepler Capital
Upgraded
03/13/25
Jefferies
Reiterated
03/11/25
Goldman Sachs
Reiterated
03/11/25
Bernstein
Reiterated
03/10/25
Stifel Nicolaus
kr780→kr700
Hold
46.12%
Upside
Downgraded
03/03/25
Novo Nordisk downgraded to Hold from Buy at StifelNovo Nordisk downgraded to Hold from Buy at Stifel
DZ BANK AG
―
Hold
―
Reiterated
02/06/25
DZ BANK AG Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Guggenheim
kr795→kr798
Buy
66.58%
Upside
Reiterated
01/17/25
Novo Nordisk price target raised to DKK 798 from DKK 795 at GuggenheimNovo Nordisk price target raised to DKK 798 from DKK 795 at Guggenheim
Handelsbanken Capital
kr1,000
Buy
108.75%
Upside
Upgraded
12/23/24
Novo Nordisk upgraded to Outperform from Market Perform at HandelsbankenNovo Nordisk upgraded to Outperform from Market Perform at Handelsbanken
Barclays
kr1,050→kr900
Buy
87.87%
Upside
Reiterated
12/23/24
Novo Nordisk price target lowered to DKK 900 from DKK 1,050 at BarclaysNovo Nordisk price target lowered to DKK 900 from DKK 1,050 at Barclays
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
Reiterated
03/28/25
Bank of America Securities
Reiterated
03/28/25
Morgan Stanley
Reiterated
03/27/25
Berenberg Bank
Reiterated
03/24/25
Deutsche Bank
Reiterated
03/24/25
Kepler Capital
Upgraded
03/13/25
Jefferies
Reiterated
03/11/25
Goldman Sachs
Reiterated
03/11/25
Bernstein
Reiterated
03/10/25
Stifel Nicolaus
kr780→kr700
Hold
46.12%
Upside
Downgraded
03/03/25
Novo Nordisk downgraded to Hold from Buy at StifelNovo Nordisk downgraded to Hold from Buy at Stifel
DZ BANK AG
―
Hold
―
Reiterated
02/06/25
DZ BANK AG Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Guggenheim
kr795→kr798
Buy
66.58%
Upside
Reiterated
01/17/25
Novo Nordisk price target raised to DKK 798 from DKK 795 at GuggenheimNovo Nordisk price target raised to DKK 798 from DKK 795 at Guggenheim
Handelsbanken Capital
kr1,000
Buy
108.75%
Upside
Upgraded
12/23/24
Novo Nordisk upgraded to Outperform from Market Perform at HandelsbankenNovo Nordisk upgraded to Outperform from Market Perform at Handelsbanken
Barclays
kr1,050→kr900
Buy
87.87%
Upside
Reiterated
12/23/24
Novo Nordisk price target lowered to DKK 900 from DKK 1,050 at BarclaysNovo Nordisk price target lowered to DKK 900 from DKK 1,050 at Barclays
0QIU Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
1
9
14
20
Buy
27
24
29
26
25
Hold
19
20
19
19
17
Sell
3
7
8
8
4
Strong Sell
0
0
0
0
0
total
49
52
65
67
66
Each month's total comprises the sum of three months' worth of ratings.
0QIU Financial Forecast
0QIU Stock Forecast FAQ
What is GB:0QIU’s average 12-month price target, according to analysts?
Based on analyst ratings, Novo Nordisk’s 12-month average price target is kr743.58.
What is GB:0QIU’s upside potential, based on the analysts’ average price target?
Novo Nordisk has 55.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novo Nordisk a Buy, Sell or Hold?
Novo Nordisk has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 5 hold ratings and 1 sell ratings.
What is Novo Nordisk’s share price target?
The average share price target for Novo Nordisk is kr743.58. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr1,000.00 ,and the lowest forecast is kr515.00. The average share price target represents 55.22% Increase from the current price of kr479.05.
The highest analyst share price target is kr1,000.00 ,and the lowest forecast is kr515.00. The average share price target represents 55.22% Increase from the current price of kr479.05.
What do analysts say about Novo Nordisk?
Novo Nordisk’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Novo Nordisk?
To buy shares of GB:0QIU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.